GGrantIndex
Sort

172,184 grants matching inflammation

Clinical Research and Protocol Support Services

$4,193,882
William O'Donnell · National Eye Institute · ZID · FY2009 · EY

Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center

$4,191,059
Joseph B. Margolick · Johns Hopkins University · U01 · FY2021 · HL

Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina

$4,190,009
Rachel R. Caspi · National Eye Institute · ZIA · FY2024 · EY

Optimization Of HIV Specific Immune Responses In Vivo

$4,186,577
Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Optimization Of HIV Specific Immune Responses In Vivo

$4,186,577
Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

Environmental Influences on Child Health Outcomes in the Northern Plains Safe Passage Study Cohort

$4,158,962
Amy J Elliott · Avera Mckennan · UH3 · FY2022 · OD

Environmental Influences on Child Health Outcomes in the Northern Plains Safe Passage Study Cohort

$4,158,962
Amy J Elliott · Avera Mckennan · UH3 · FY2021 · OD

Trial to Assess Chelation Therapy (TACT)

$4,151,803
Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach) · U01 · FY2009 · HL

CARDIA

$4,151,384
Sharina D. Person · University Of Alabama At Birmingham · N01 · FY2009 · HL

Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)

$4,150,133
Kathryn M Anastos · Albert Einstein College Of Medicine · U01 · FY2022 · HL

Systems Immunogenetics of Biodefense Pathogens in the Collaborative Cross

$4,148,261
Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI

Systems Immunogenetics of Biodefense Pathogens in the Collaborative Cross

$4,144,540
Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI

Novel, Non-antibiotic Therapy for Clostridium difficile-Associated Disease

$4,143,652
Gerald P Donovan · Progenics Pharmaceuticals, Inc. · RC4 · FY2010 · AI

Film Antiretroviral Microbicide Evaluation

$4,141,533
Sharon L Hillier · Magee-Women'S Res Inst And Foundation · U19 · FY2015 · AI

Defining Common Molecular Parameters For Onset and Progression of Osteoarthritis

$4,140,386
Mary B. Goldring · Hospital For Special Surgery · RC4 · FY2010 · AR

Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study

$4,139,640
John Morris · Washington University · P01 · FY2024 · AG

Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)

$4,137,839
Anjali Sharma · Albert Einstein College Of Medicine · U01 · FY2024 · HL

Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study

$4,136,684
John Morris · Washington University · P01 · FY2023 · AG

Mapping the Human Connectome During Typical Aging

$4,132,562
David C Van Essen · Washington University · U01 · FY2019 · AG

Obesity, Body Fat Distribution, and Cancer Risk in the Multiethnic Cohort

$4,121,831
Loic Le Marchand · University Of Hawaii At Manoa · P01 · FY2015 · CA

Environment, Epigenetics, Neurodevelopment & Health of Extremely Preterm Children

$4,119,664
T Michael O'Shea · Univ Of North Carolina Chapel Hill · UH3 · FY2018 · OD

Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center

$4,110,891
Joseph B. Margolick · Johns Hopkins University · U01 · FY2023 · HL

Environment, Epigenetics, Neurodevelopment & Health of Extremely Preterm Children

$4,110,690
T Michael O'Shea · Univ Of North Carolina Chapel Hill · UH3 · FY2020 · OD

Environment, Epigenetics, Neurodevelopment & Health of Extremely Preterm Children

$4,110,690
T Michael O'Shea · Univ Of North Carolina Chapel Hill · UH3 · FY2021 · OD

PItt-Ohio State-Georgetown Clinical Trials Unit

$4,102,856
John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2014 · AI